top of page
The Professional Network for Healthcare Experts
Henlius and Sandoz expand biosimilars partnership to cover up to 10 global programmes
The portfolio collaboration combines Henlius’ biologics development and manufacturing capabilities with Sandoz’s ex-China commercial infrastructure, initially covering three biosimilars and an option on a recombinant human hyaluronidase programme.
nuaxia
16 hours ago3 min read
Henlius and Sandoz expand biosimilars partnership with up to 10 global programmes
The collaboration combines Henlius’ biologics development, manufacturing and supply capabilities with Sandoz’s ex-China commercial infrastructure, initially covering three biosimilars and an option on a recombinant human hyaluronidase programme.
nuaxia
2 days ago3 min read
bottom of page